A citation-based method for searching scientific literature

Shalamar D Sibley, Jerry P Palmer, Irl B Hirsch, John D Brunzell. J Clin Endocrinol Metab 2003
Times Cited: 47

List of co-cited articles
273 articles co-cited >1

Times Cited
  Times     Co-cited

Can clinical factors estimate insulin resistance in type 1 diabetes?
K V Williams, J R Erbey, D Becker, S Arslanian, T J Orchard. Diabetes 2000

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Trevor J Orchard, Jon C Olson, John R Erbey, Katherine Williams, Kimberly Y-Z Forrest, Leslie Smithline Kinder, Demetrius Ellis, Dorothy J Becker. Diabetes Care 2003

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.
Samir S Deeb, Alberto Zambon, Molly C Carr, Amir F Ayyobi, John D Brunzell. J Lipid Res 2003

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.
S P Laing, A J Swerdlow, S D Slater, A C Burden, A Morris, N R Waugh, W Gatling, P J Bingley, C C Patterson. Diabetologia 2003

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
Lena M Thorn, Carol Forsblom, Johan Fagerudd, Merlin C Thomas, Kim Pettersson-Fernholm, Markku Saraheimo, Johan Wadén, Mats Rönnback, Milla Rosengård-Bärlund, Clas-Göran Af Björkesten,[...]. Diabetes Care 2005

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.
Jill Hamilton, Elizabeth Cummings, Vera Zdravkovic, Diane Finegood, Denis Daneman. Diabetes Care 2003

The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity.
M C Carr, J E Hokanson, A Zambon, S S Deeb, P H Barrett, J Q Purnell, J D Brunzell. J Clin Endocrinol Metab 2001

Hepatic lipase: structure/function relationship, synthesis, and regulation.
Bertrand Perret, Laurence Mabile, Laurent Martinez, François Tercé, Ronald Barbaras, Xavier Collet. J Lipid Res 2002

Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone.
Gary F Lewis, Susan Murdoch, Kristine Uffelman, Mark Naples, Linda Szeto, Alegria Albers, Khosrow Adeli, John D Brunzell. Diabetes 2004

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
Sabita S Soedamah-Muthu, Nish Chaturvedi, Monika Toeller, Barry Ferriss, Paolo Reboldi, Georges Michel, Christos Manes, John H Fuller. Diabetes Care 2004

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women.
J P Després, M Ferland, S Moorjani, A Nadeau, A Tremblay, P J Lupien, G Thériault, C Bouchard. Arteriosclerosis 1989

Insulin resistance is a prominent feature of insulin-dependent diabetes.
R A DeFronzo, R Hendler, D Simonson. Diabetes 1982

Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.
J Yip, M B Mattock, A Morocutti, M Sethi, R Trevisan, G Viberti. Lancet 1993

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.
Jon C Olson, John R Erbey, Kimberly Y Z Forrest, Katherine Williams, Dorothy J Becker, Trevor J Orchard. Metabolism 2002

The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients.
Laurent Meyer, Philip Bohme, Irene Delbachian, Philippe Lehert, Nathalie Cugnardey, Pierre Drouin, Bruno Guerci. Diabetes Care 2002

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease.
A Zambon, M A Austin, B G Brown, J E Hokanson, J D Brunzell. Arterioscler Thromb 1993

Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men.
J Q Purnell, S E Kahn, J J Albers, D N Nevin, J D Brunzell, R S Schwartz. J Clin Endocrinol Metab 2000

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
Joshua A Beckman, Mark A Creager, Peter Libby. JAMA 2002

Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients.
H Jansen, A J Verhoeven, L Weeks, J J Kastelein, D J Halley, A van den Ouweland, J W Jukema, J C Seidell, J C Birkenhäger. Arterioscler Thromb Vasc Biol 1997

Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus.
A Caixàs, A Pérez, A Payés, C Otal, G Carreras, J Ordóñez-Llanos, J Reviriego, J H Anderson, A de Leiva. Metabolism 1998

Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
G Ruotolo, M Parlavecchia, M R Taskinen, G Galimberti, A Zoppo, N A Le, F Ragogna, P Micossi, G Pozza. Diabetes Care 1994

Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
Alicia J Jenkins, Timothy J Lyons, Deyi Zheng, James D Otvos, Daniel T Lackland, Daniel McGee, W Timothy Garvey, Richard L Klein. Diabetes Care 2003

Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965-1999.
R Nishimura, R E LaPorte, J S Dorman, N Tajima, D Becker, T J Orchard. Diabetes Care 2001

The effect of rosiglitazone on overweight subjects with type 1 diabetes.
Suzanne M Strowig, Philip Raskin. Diabetes Care 2005

Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.
Jonathan Q Purnell, Raj K Dev, Michael W Steffes, Patricia A Cleary, Jerry P Palmer, Irl B Hirsch, John E Hokanson, John D Brunzell. Diabetes 2003

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.
J S Dorman, R E Laporte, L H Kuller, K J Cruickshanks, T J Orchard, D K Wagener, D J Becker, D E Cavender, A L Drash. Diabetes 1984

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.
Christophe E M De Block, Ivo H De Leeuw, Luc F Van Gaal. Diabetes Care 2005

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Debra A Schaumberg, Robert J Glynn, Alicia J Jenkins, Timothy J Lyons, Nader Rifai, JoAnn E Manson, Paul M Ridker, David M Nathan. Circulation 2005

Cardiovascular morbidity and mortality associated with the metabolic syndrome.
B Isomaa, P Almgren, T Tuomi, B Forsén, K Lahti, M Nissén, M R Taskinen, L Groop. Diabetes Care 2001

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
Sabita S Soedamah-Muthu, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun. Diabetes Care 2006

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.